Edition:
United Kingdom

Aldeyra Therapeutics Inc (ALDX.OQ)

ALDX.OQ on NASDAQ Stock Exchange Capital Market

7.76USD
15 Feb 2019
Change (% chg)

$-0.21 (-2.63%)
Prev Close
$7.97
Open
$8.02
Day's High
$8.02
Day's Low
$7.52
Volume
70,775
Avg. Vol
63,019
52-wk High
$16.70
52-wk Low
$6.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.516
Jun '18 0.00 -0.458
Mar '18 0.00 -0.434
FY 2017 Dec '17 0.00 -0.363
Sep '17 0.00 -0.320
Jun '17 0.00 -0.351
Mar '17 0.00 -0.369
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Quarter Ending Jun-19 3 0.00 0.00 0.00 --
Year Ending Dec-19 6 0.05 0.28 0.00 5.71
Earnings (per share)
Quarter Ending Mar-19 4 -0.43 -0.36 -0.54 --
Quarter Ending Jun-19 4 -0.48 -0.40 -0.65 --
Year Ending Dec-19 7 -2.14 -1.60 -3.73 -2.06
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta 0.64 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) 4.77 10.14 5.26
Price to Tangible Book (MRQ) 5.86 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 59.56 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -25.02 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 7.20 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 12.47 3.50 3.08
LT Debt to Equity (MRQ) 4.35 18.65 11.38
Total Debt to Equity (MRQ) 5.68 31.33 16.12
Interest Coverage (TTM) -331.44 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.45 12.86
Operating Margin (TTM) -- -184.67 6.20
Operating Margin - 5 Yr. Avg. -- -126.94 8.31
Pre-Tax Margin (TTM) -- -175.36 7.16
Pre-Tax Margin - 5 Yr. Avg. -- -132.73 8.61
Net Profit Margin (TTM) -- -182.07 3.29
Net Profit Margin - 5 Yr. Avg. -- -137.12 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,654,354 842,397,297
Net Income/Employee (TTM) -- 562,076 99,842,671
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.81 6.39 11.06
Return on Assets - 5 Yr. Avg. -82.96 5.47 12.20
Return on Investment (TTM) -72.27 8.92 14.45
Return on Investment - 5 Yr. Avg. -94.67 6.78 15.87
Return on Equity (TTM) -75.02 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -17.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aldeyra Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 77.11 71.00 97 99
13 Week 50.00 42.70 89 95
26 Week 44.12 33.16 80 98
52 Week 3.81 -12.01 54 72
YTD 37.38 20.65 68 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.11%
# of Holders: 106
Total Shares Held: 19,974,371
3 Mo. Net Change: -1,635,696
# New Positions: 14
# Closed Positions: 28
# Increased Positions: 58
# Reduced Positions: 47
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.